These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31986084)

  • 41. Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation.
    Gorshein E; Wei C; Ambrosy S; Budney S; Vivas J; Shenkerman A; Manago J; McGrath MK; Tyno A; Lin Y; Patel V; Gharibo M; Schaar D; Jenq RR; Khiabanian H; Strair R
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28256022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of intestinal microbiota in transplantation outcomes.
    Taur Y; Jenq RR; Ubeda C; van den Brink M; Pamer EG
    Best Pract Res Clin Haematol; 2015; 28(2-3):155-61. PubMed ID: 26590773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
    Weber D; Hiergeist A; Weber M; Ghimire S; Salzberger B; Wolff D; Poeck H; Gessner A; Edinger M; Herr W; Meedt E; Holler E
    Clin Infect Dis; 2023 Nov; 77(10):1432-1439. PubMed ID: 37386935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
    Markey KA; Schluter J; Gomes ALC; Littmann ER; Pickard AJ; Taylor BP; Giardina PA; Weber D; Dai A; Docampo MD; Armijo GK; Slingerland AE; Slingerland JB; Nichols KB; Brereton DG; Clurman AG; Ramos RJ; Rao A; Bush A; Bohannon L; Covington M; Lew MV; Rizzieri DA; Chao N; Maloy M; Cho C; Politikos I; Giralt S; Taur Y; Pamer EG; Holler E; Perales MA; Ponce DM; Devlin SM; Xavier J; Sung AD; Peled JU; Cross JR; van den Brink MRM
    Blood; 2020 Jul; 136(1):130-136. PubMed ID: 32430495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics.
    Weber D; Hiergeist A; Weber M; Dettmer K; Wolff D; Hahn J; Herr W; Gessner A; Holler E
    Clin Infect Dis; 2019 Apr; 68(8):1303-1310. PubMed ID: 30124813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms.
    Nguyen CL; Docampo MD; van den Brink MR; Markey KA
    Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gut microbiota in transplant patients.
    Chong PP; Koh AY
    Blood Rev; 2020 Jan; 39():100614. PubMed ID: 31492463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients.
    Greco R; Nitti R; Mancini N; Pasciuta R; Lorentino F; Lupo-Stanghellini MT; Barbanti MC; Clementi N; Giglio F; Clerici D; Marktel S; Assanelli A; Carrabba MG; Bernardi M; Corti C; Peccatori J; Clementi M; Ciceri F
    Blood; 2021 Mar; 137(11):1556-1559. PubMed ID: 33171492
    [No Abstract]   [Full Text] [Related]  

  • 49. Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.
    Huang Z; Li Y; Park H; Ho M; Bhardwaj K; Sugimura N; Lee HW; Meng H; Ebert MP; Chao K; Burgermeister E; Bhatt AP; Shetty SA; Li K; Wen W; Zuo T
    Gut Microbes; 2023; 15(1):2237645. PubMed ID: 37498052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microbiome-Induced Autoimmunity and Novel Therapeutic Intervention.
    Evrensel A
    Adv Exp Med Biol; 2023; 1411():71-90. PubMed ID: 36949306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
    Daoud-Asfour H; Henig I; Ghersin I; Rakedzon S; Stern A; Pitashny M; Zuckerman T; Bar-Yoseph H
    Transplant Cell Ther; 2022 Mar; 28(3):168.e1-168.e8. PubMed ID: 34954293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
    Margolis EB; Alfaro GM; Sun Y; Dallas RH; Allison KJ; Ferrolino J; Ross HS; Davis AE; Jia Q; Turner P; Mackay V; Morin CE; Triplett BM; Klein EJ; Englund JA; Tang L; Hayden RT
    J Infect Dis; 2023 Aug; 228(5):627-636. PubMed ID: 37249910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Induction and regulation of intestinal graft-versus-host disease by the intestinal microbiota].
    Hayase E
    Rinsho Ketsueki; 2024; 65(9):1140-1147. PubMed ID: 39358271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human microbiome restoration and safety.
    Daliri EB; Tango CN; Lee BH; Oh DH
    Int J Med Microbiol; 2018 Jul; 308(5):487-497. PubMed ID: 29773467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets.
    Van Lier YF; Van den Brink MRM; Hazenberg MD; Markey KA
    Haematologica; 2021 Aug; 106(8):2042-2053. PubMed ID: 33882637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of Gut Microbiota in Complex Human Diseases.
    Yu D; Meng X; de Vos WM; Wu H; Fang X; Maiti AK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation.
    Ingham AC; Kielsen K; Cilieborg MS; Lund O; Holmes S; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2019 Sep; 7(1):131. PubMed ID: 31519210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.
    Whangbo J; Ritz J; Bhatt A
    Bone Marrow Transplant; 2017 Feb; 52(2):183-190. PubMed ID: 27526283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.